What is the price target for CDNA stock?
15 analysts have analysed CDNA and the average price target is 25.67 USD. This implies a price increase of 45.6% is expected in the next year compared to the current price of 17.63.
CAREDX INC (CDNA) Forecast, Price Target & Analyst Ratings
NASDAQ:CDNA • US14167L1035
Current stock price
17.63 USD
+0.8 (+4.75%)
At close:
17.5 USD
-0.13 (-0.74%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CAREDX INC (CDNA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 104.33M
Price Target Details & History
Consensus Price Target and Range
Mean target
$25.67
Upside
+ 45.60%
From current price of $17.63 to mean target of $25.67, Based on 15 analyst forecasts
Low
$21.21
Median
$26.52
High
$29.40
Price Target Revisions
1 Month
4.86%
3 Months
9.42%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for CDNA. The average price target is 25.67 USD. This implies a price increase of 45.6% is expected in the next year compared to the current price of 17.63.
The average price target has been revised upward by 9.42% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.67%
CDNA was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about CDNA.
In the previous month the buy percentage consensus was at a similar level.
CDNA was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | BTIG | Maintains | Buy -> Buy |
| 2026-02-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-09-23 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-12 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-26 | William Blair | Initiate | Market Perform |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-18 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-05-05 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-04-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-02-27 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-01-15 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-05 | BTIG | Maintains | Buy -> Buy |
| 2024-10-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-10-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-27 | Wells Fargo | Initiate | Underweight |
| 2024-08-19 | BTIG | Upgrade | Neutral -> Buy |
| 2024-08-01 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-01 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-07-17 | Goldman Sachs | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 104.33M
- Revenue Q2Q
- 23.20%
- EPS Q2Q
- 52.35%
- Number of Analysts
- 11
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
1.72%
EPS (1 Month)
0.00%
EPS (3 Months)
-36.29%
Next Earnings Summary
CDNA is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is 0.14 USD and the consensus revenue estimate is 104.33M USD.
The next earnings revenue estimate has been revised upward by 1.72% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 280.324M -12.89% | 333.785M 19.07% | 379.805M 13.79% | 440.6M 16.01% | 490.43M 11.31% | 538.95M 9.89% | |
| EBITDA YoY % growth | -89.657M -36.67% | -39.558M 55.88% | -10.053M 74.59% | 39.411M 492.03% | 62.141M 57.67% | 84.221M 35.53% | |
| EBIT YoY % growth | -104.043M -34.77% | -53.752M 48.34% | -25.071M 53.36% | 24.247M 196.71% | 47.203M 94.68% | 55.457M 17.49% | |
| Operating Margin | -37.12% | -16.10% | -6.60% | 5.50% | 9.62% | 10.29% | |
| EPS YoY % growth | -0.64 -64.10% | 0.54 184.38% | 0.59 9.26% | 0.71 21.09% | 1.11 55.09% | 1.65 49.35% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.14 52.35% | 0.18 79.66% | 0.19 -33.39% | 0.21 76.68% | 0.22 60.98% | 0.26 42.50% | 0.28 51.26% | 0.33 53.47% |
| Revenue Q2Q % growth | 104.33M 23.20% | 108.73M 25.44% | 111.48M 11.42% | 116.26M 7.26% | 114.92M 10.15% | 119.72M 10.11% | 123.95M 11.19% | 129.97M 11.79% |
| EBITDA Q2Q % growth | 7.9M 278.98% | 9.575M 377.62% | 10.229M -22.45% | 11.639M 29.64% | 12.345M 56.27% | 14.303M 49.38% | 15.894M 55.38% | 19.107M 64.16% |
| EBIT Q2Q % growth | 3.22M 140.18% | 5.604M 152.03% | 4.798M 133.59% | 5.975M 198.92% | 7.429M 130.71% | 9.188M 63.95% | 10.019M 108.82% | 12.534M 109.77% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
41.02%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
12.14%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
43.44%
EBIT Next 5 Year
N/A
CAREDX INC / CDNA Forecast FAQ
When does CAREDX INC (CDNA) report earnings?
CAREDX INC (CDNA) will report earnings on 2026-04-30, after the market close.
What are the consensus estimates for CAREDX INC (CDNA) next earnings?
The consensus EPS estimate for the next earnings of CAREDX INC (CDNA) is 0.14 USD and the consensus revenue estimate is 104.33M USD.
How many analysts have analysed CAREDX INC (CDNA)?
The number of analysts covering CAREDX INC (CDNA) is 15.